Fulgent Genetics, Inc. FLGT 深 滬
等待開盤 11-26 09:30:00 美东时间
30.85
+0.200
+0.65%
華盛通- 最 高31.04
- 今 開30.85
- 成交量 29.94万股
- 最 低 30.715
- 昨 收 30.65
- 總市值 9.44亿
- 52周最高 31.04
- 市盈率 靜 --
- 換手率 0.98%
- 52周最低 14.57
- 委 比 -74.63%
- 總股本 3060.90万
- 歷史最高 189.89
- 量 比 0.83
- 振 幅 1.06%
- 歷史最低 2.725
- 每 手 1
- 風險率 2.91%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
11-12 11:43
Piper Sandler Maintains Neutral on Fulgent Genetics, Raises Price Target to $30
Piper Sandler analyst David Westenberg maintains Fulgent Genetics (NASDAQ:FLGT) with a Neutral and raises the price target from $21 to $30.
11-12 01:02
Fulgent Genetics Raises 2025 Revenue Guidance
Fulgent Genetics ( ($FLGT) ) just unveiled an update. Fulgent Genetics reported...
11-07 20:28
Fulgent Genetics Raises FY2025 GAAP EPS Guidance from $(2.10) to $(1.70) vs $(1.94) Est
Fulgent Genetics (NASDAQ:FLGT) raises FY2025 GAAP EPS guidance from $(2.10) to $(1.70) vs $(1.94) analyst estimate..
11-07 20:08
Fulgent Genetics Q3 Adj. EPS $0.14 Beats $(0.22) Estimate, Sales $84.069M Beat $81.431M Estimate
Fulgent Genetics (NASDAQ:FLGT) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $(0.22) by 162.78 percent. This is a 54.84 percent decrease over earnings of $0.31 per share from
11-07 20:06
Earnings Scheduled For November 7, 2025
Companies Reporting Before The Bell • Kiora Pharmaceuticals (NASDAQ:KPRX) is pr...
11-07 19:11
Fulgent Genetics's Earnings Outlook
Fulgent Genetics (NASDAQ:FLGT) is gearing up to announce its quarterly earnings...
11-06 23:03
A Glimpse of Castle Biosciences's Earnings Potential
Castle Biosciences (NASDAQ:CSTL) will release its quarterly earnings report on ...
11-01 03:03
Fulgent Genetics Reports Phase 2 Cancer Drug Results Ahead Of ESMO 2025 Presentation
Fulgent Genetics, Inc. (NASDAQ:FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced preliminary
10-20 18:11
A Preview Of Performant Healthcare's Earnings
Performant Healthcare (NASDAQ:PHLT) is gearing up to announce its quarterly ear...
08-07 03:03
